There’s No Getting Around Elanco Animal Health Incorporated (NYSE: ELAN) Success

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for Elanco Animal Health Incorporated (ELAN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.18, or 2.07%, to $8.88. The Elanco Animal Health Incorporated has recorded 40,677 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Elanco Animal Health Reports First Quarter 2023 Results.

Stocks Info

ELAN belongs to the Healthcare sector of the NYSE while operating in the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $8.70 and fluctuated between $8.72 as its day high and $8.48 as its day low. The current market capitalization of Elanco Animal Health Incorporated is $4.40B. A total of 5.12 million shares were traded on the day, compared to an average of 7.88M shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, ELAN has seen 25 BUY and 27 SELL insider trades, representing the acquisition of 1,293,087 and the disposition of 408,572 shares. Over the last 12 months, there were 43 BUYs and 31 SELLs from insiders. Insiders purchased 1,583,988 shares during that period but sold 424,309.

In the most recent transaction, HOOVER R DAVID bought 5,000 shares of ELAN for 9.55 per share on Mar 14. After the transaction, the Director now owns 165,000 company shares. In a previous transaction on Mar 13, HOOVER R DAVID bought 5,000 shares at 9.46 per share. ELAN shares that Director owns now total 160,000.

Among the insiders who bought shares, Simmons Jeffrey N acquired of 15,000 shares on Mar 10 at a per-share price of $9.60. This resulted in the PRESIDENT, CEO AND DIRECTOR holding 45,000 shares of ELAN after the transaction. In another insider transaction, HOOVER R DAVID bought 10,000 shares at $11.13 per share on Mar 03. Company shares held by the Director now total 155,000.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for ELAN in the last 3 months, the mean price target is $13.19 with high estimates of $19.00 and low estimates of $8.50. In terms of 52-week highs and lows, ELAN has a high of $24.93 and a low of $8.50.

As of this writing, ELAN has an earnings estimate of $0.05 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of $0.06 per share and a lower estimate of $0.03. The company reported an EPS of $0.19 in the last quarter, which was 46.20% higher than expectations of $0.13.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ELAN is Buy with a score of 3.44.